查看購物車
  • Simplified Chinese
  • English
2021-2031年連續血糖監測設備市場規模及預測、全球及區域佔有率、趨勢及成長機會分析報告涵蓋：產品、應用、檢測地點、最終用戶及地理
市場調查報告書
商品編碼
1858580

2021-2031年連續血糖監測設備市場規模及預測、全球及區域佔有率、趨勢及成長機會分析報告涵蓋：產品、應用、檢測地點、最終用戶及地理

Continuous Glucose Monitoring Device Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product, Application, Testing Sites, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 275 Pages | 訂單完成後即時交付

價格

預計到2031年，持續血糖監測設備（CGMD）市場規模將從2024年的127.1億美元成長至332.1億美元。該市場在2025年至2031年期間的複合年成長率（CAGR）預計為14.9%。推動市場成長的主要因素包括全球糖尿病盛行率的上升、CGM設備的技術進步以及其優於傳統血糖監測的優勢，這些因素正在促進持續血糖監測設備（CGMD）的普及。此外，與胰島素輸注系統的整合以及人工智慧驅動的決策支援功能有望在預測期內進一步推動市場成長。然而，高昂的成本、有限的報銷以及用戶舒適度和佩戴體驗方面的挑戰是限制市場發展的因素。

與傳統的血糖監測方法相比，持續血糖監測 (CGM) 設備具有顯著且具有臨床意義的優勢，從根本上改變了全球數百萬名糖尿病患者的管理方式。與依賴定期指尖採血的傳統方法不同，CGM 透過微創感測器提供即時、連續的血糖值測量，使用戶和臨床醫生能夠評估血糖波動和趨勢，而不是僅僅依賴單一資料點。近期臨床研究表明，CGM 的使用可使糖化血紅蛋白 (HbA1c) 水平降低 0.25% 至 3.0%，並將「目標範圍內時間」（血糖水平在目標範圍內的時間百分比）提高 15% 至 34%，這兩項指標的提高均與降低糖尿病併發症風險和改善長期預後相關。

持續血糖監測 (CGM) 技術最具影響力的進展之一是其能夠即時發出低血糖和高血糖警報。這些警報能夠促使醫護人員立即採取干涉措施，例如及時補充碳水化合物或調整胰島素劑量，從而顯著降低危險事件的發生頻率和嚴重程度。研究表明，新型 CGM 中整合的低血糖預測演算法可以將血糖低於目標範圍的時間減少高達 92%（與無警報相比）和 47%（與標準警報相比），從而顯著提高安全性，尤其是在睡眠期間或對於低血糖高風險患者而言。此外，夜間低血糖預測技術已證實可將夜間血糖低於安全閾值的時間減少 37%，從而在血糖脆弱時段提供有效保護。

持續血糖監測（CGM）是一種變革性的教育工具，它透過將飲食攝取、身體活動、藥物反應和壓力因素與相應的血糖波動關聯起來，從而激勵患者進行個人化的生活方式改變。這種持續的視覺回饋能夠增強患者的自我管理能力和參與度，提供的洞察遠勝於缺乏即時和個人化生理資料的傳統教育方法。這種持續的資料流能夠實現動態的糖尿病管理，使患者和醫護人員能夠做出積極主動、基於循證醫學的決策，在兩次就診之間調整治療方案，並識別出以前未被注意到的模式，例如餐後血糖峰值或夜間高血糖。

持續血糖監測（CGM）也能為醫療服務提供者提供詳細且全面的血糖譜，包括目標範圍內時間、低血糖/高血糖發生頻率和血糖波動等指標。這有助於更精準地強化治療、進行風險分層和製定預防策略，從而降低住院率並避免嚴重併發症。透過整合無線資料傳輸和雲端存儲，可以遠端監測患者資料，從而簡化醫療服務流程並提高患者依從性。這對於兒童、老年人、孕婦和低血糖感知障礙患者等弱勢群體尤其重要。

持續血糖監測（CGM）消除了頻繁指尖採血帶來的實際和心理負擔，而指尖採血正是早期血糖監測方法的一個局限性，影響了患者的依從性和生活品質。兒童尤其重視這種「無需指尖採血」的方法，接受強化治療的患者儘管面臨成本和設備複雜性方面的挑戰，但仍報告了更高的治療滿意度和長期設備留存率。

持續血糖監測（CGM）顯著改善了血糖控制指標，有效預防了低血糖，透過即時資料增強了患者的自主性，為醫療團隊提供了可操作的指標支持，並提高了患者的整體生活品質。鑑於這些經臨床驗證的益處，國際糖尿病照護標準強烈建議將CGM用於第1型糖尿病，並不斷擴大其在第2型糖尿病中的應用範圍。這進一步鞏固了CGM作為現代糖尿病照護基石的地位。

本報告透過比較分析，基於產品組合（產品滿意度、產品特性和可用性）、近期市場發展（併購、新產品發布與改進、投資與融資、獎項、協議、合作與夥伴關係、認可和擴張）以及地域分佈，對持續血糖監測設備 (CGMD) 市場進行評估和分類，從而幫助企業更好地進行決策併了解競爭格局。報告深入探討了全球持續血糖監測設備 (CGMD) 市場領先供應商近期取得的重大進展和創新。主要市場參與者包括：雅培實驗室 (Abbott Laboratories)、德康醫療 (Dexcom Inc.)、Ypsomed Holding AG、美敦力 (Medtronic)、羅氏 (F. Hoffmann-La Roche Ltd)、Senseonics Holdings Inc、i-SENS Inc.、A. Menarini Diagnostics srl、Tandem​​i 和 Diagnostics Inc., Diagnostics Inc.D.S.k.

根據產品類型，連續血糖監測設備（CGMD）市場可分為感測器、發射器和接收器。 2024年，感測器部分佔據了最大的市場佔有率。

依應用領域分類，市場可分為第1型糖尿病和第2型糖尿病。 2024年，第2型糖尿病領域佔據了連續血糖監測設備（CGMD）市場最大的佔有率。

依檢測部位分類，市場可分為指尖檢測和其他部位檢測。 2024年，指尖檢測在連續血糖監測設備（CGMD）市場中佔據最大佔有率。指尖血糖檢測，也稱為自我血糖監測（SMBG），長期以來一直是糖尿病管理的基礎。它透過刺穿手指並將一滴血滴到血糖儀上，直接讀取毛細血管血液樣本。儘管連續血糖監測儀（CGM）因其連續且注重趨勢的資料而日益佔據主導地位，但指尖採血對於校準（在某些CGM中）以及在血糖快速變化或懷疑測量錯誤時進行確認仍然至關重要。

準確性仍然是自我血糖監測 (SMBG) 的優勢之一。現代指尖血糖儀的平均絕對相對差異 (MARD) 通常較低，一般在 5-6% 範圍內，而 Dexcom G7 和 FreeStyle Libre 3 等頂級動態血糖監測儀 (CGM) 的 MARD 則在 8-9% 左右。這種準確性優勢在需要精確血糖讀數的情況下尤其重要，例如確認低血糖或校準 CGM。延遲時間和組織液與毛細血管液的差異仍然是關鍵差異。 CGM 測量的是組織液葡萄糖，其讀數通常比血糖滯後​​約 5-15 分鐘。而指尖血糖檢測可以立即提供真實的毛細血管葡萄糖水平，因此在血糖快速變化或設備警報與症狀不符時，指尖血糖檢測尤為重要。

就最終用戶而言，持續血糖監測設備（CGMD）市場可細分為醫院和診所，以及自我或居家照護。到2024年，自我或居家照護細分市場佔據了持續血糖監測設備（CGMD）市場的最大佔有率。

在連續血糖監測設備 (CGMD) 市場中營運的公司採用多種有機和無機成長策略。有機成長策略主要包括產品發布和產品批准。無機成長策略則包括收購、合作和夥伴關係。這些成長策略使市場參與者能夠拓展業務、增強地域覆蓋範圍，並促進整體市場成長。此外，收購和夥伴關係還有助於鞏固客戶基礎並擴展產品組合。以下列舉了部分主要連續血糖監測設備 (CGMD) 市場參與者的重要發展動態。

2025年7月，雅培公司兩款新型非處方（OTC）連續血糖監測系統Lingo和Libre Rio獲得美國食品藥物管理局（FDA）批准。這兩款產品均基於FreeStyle Libre技術，將血糖監測的應用範圍從傳統的糖尿病管理擴展到一般健康和保健領域。這是物聯網醫療設備消費化過程中的重要一步。

2025年7月，德康醫療（Dexcom, Inc.）宣布，其為Stelo（美國首款獲得FDA批准的非處方血糖生物感測器）推出了一項全新的AI驅動的餐食照片記錄功能。 Dexcom的智慧餐點記錄功能旨在鼓勵並幫助使用者更規律地記錄膳食。 Stelo和Dexcom G7用戶現在可以在應用程式中拍攝食物照片，AI會自動識別食材並產生餐點描述。 Dexcom G7是美國目前唯一支援餐點照片記錄功能的處方級連續血糖監測儀。

2025年4月，德康公司宣布，美國食品藥物管理局（FDA）已批准其Dexcom G7 15天連續血糖監測系統用於美國18歲以上糖尿病患者。 Dexcom G7 15天連續血糖監測系統整體平均絕對相對偏差（MARD）為8.0%，其性能優於Dexcom CGM，經臨床驗證可降低糖化血紅蛋白（A1C）水平，減少高血糖和低血糖，並增加血糖達標時間。

目錄

第1章：引言

第2章：執行概要

  • 分析師市場展望
  • 市場吸引力

第3章：研究方法

  • 二手研究
  • 初步研究
    • 假設的提出：
    • 宏觀經濟因素分析：
    • 發展基礎數字：
    • 數據三角測量：
    • 國家層面資料：
  • 假設和局限性

第4章：連續血糖監測設備（CGMD）市場概況

  • 概述
  • PEST分析

第5章：連續血糖監測設備（CGMD）市場－主要市場動態

  • 連續血糖監測設備（CGMD）市場－主要市場動態
  • 市場促進因素
    • 全球糖尿病盛行率不斷上升
    • CGM設備技術的快速發展
    • 與傳統血糖監測相比的優勢
  • 市場限制
    • 高昂的成本和有限的報銷
    • 使用者舒適度和配戴舒適度方面的挑戰
  • 市場機遇
    • 提高新興市場和低度開發市場的可近性
  • 未來趨勢
    • 與胰島素輸送和人工智慧驅動的決策支援系統整合
  • 駕駛員和安全帶的影響：

第6章：連續血糖監測設備（CGMD）市場－全球市場分析

  • 2021-2031年連續血糖監測設備（CGMD）市場收入
  • 連續血糖監測設備（CGMD）市場預測分析

第7章：連續血糖監測設備（CGMD）市場分析－依產品分類

  • 感應器
  • 發射器
  • 接收器

第8章：連續血糖監測設備（CGMD）市場分析－依應用領域分類

  • 1型糖尿病
  • 2型糖尿病

第9章：連續血糖監測設備（CGMD）市場分析－依檢測點分類

  • 指尖測試
  • 備選測試地點

第10章：連續血糖監測設備（CGMD）市場分析－依最終使用者分類

  • 醫院和診所
  • 自我照顧或居家護理

第11章：連續血糖監測設備（CGMD）市場－地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 亞太其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第12章：競爭格局

  • 關鍵參與者熱力圖分析
  • 公司定位與集中度

第13章：全球連續血糖監測設備市場產業概況

  • 概述
  • 產品上市，產品核准
  • 擴張及其他策略發展

第14章：公司簡介

  • Abbott Laboratories
  • Dexcom Inc
  • Ypsomed Holding AG
  • Medtronic Plc
  • F. Hoffmann-La Roche Ltd
  • Senseonics Holdings Inc
  • i-SENS Inc
  • A. Menarini Diagnostics s.r.l
  • Tandem Diabetes Care Inc
  • Medtrum Technologies Inc.

第15章：附錄

Product Code: TIPRE00018031

The continuous glucose monitoring device (CGMD) market is projected to reach US$33.21 billion by 2031 from US$12.71 billion in 2024. The market is estimated to register a CAGR of 14.9% during 2025-2031. Major factors driving the market growth include a rising global prevalence of diabetes, technological advancements in CGM devices, and benefits over conventional glucose monitoring are propelling the adoption of continuous glucose monitoring device (CGMD). Further, integration with insulin delivery and AI-driven decision support will likely boost the market during the forecast period. However, the high cost and limited reimbursement and user comfort and wearability challenges are among the market deterrents.

Continuous glucose monitoring (CGM) devices offer substantial and clinically meaningful advantages over conventional blood glucose monitoring methods, fundamentally transforming diabetes management for millions worldwide. Unlike traditional approaches that rely on periodic finger-prick tests, CGMs provide real-time, continuous measurement of glucose levels via minimally invasive sensors, allowing users and clinicians to assess glucose variability and trends rather than single data points. Recent clinical studies report that CGM use achieves reductions in HbA1c levels ranging from 0.25% to 3.0% and improves "time in range" (the percentage of time glucose remains within target levels) by 15-34%, both of which are associated with lower risk of diabetes complications and improved long-term outcomes.

One of the most impactful developments in CGM technology is its ability to deliver real-time alerts for hypoglycemia and hyperglycemia. These alarms enable immediate intervention, such as prompt carbohydrate consumption or insulin dose adjustment, drastically reducing the frequency and severity of dangerous episodes. Studies show that low-glucose prediction algorithms integrated in newer CGMs can reduce time below range by up to 92% compared to no alerts and 47% compared to standard alerts, significantly improving safety, especially during sleep or for patients at high risk of hypoglycemia. Additionally, nocturnal low-glucose prediction technology has demonstrated a 37% reduction in nightly time spent below the safe glucose threshold, providing substantial protection during vulnerable hours.

CGMs are transformational educational tools, motivating personalized lifestyle change by mapping dietary intake, physical activity, medication response, and stress factors to corresponding glucose fluctuations. This ongoing visual feedback enhances self-management skills and patient engagement, offering insights far superior to conventional education methods that lack immediate and personalized physiological data. Such continuous data streams enable dynamic diabetes management, allowing patients and healthcare providers to make proactive, evidence-based decisions, adjust therapy between clinic visits, and recognize previously unnoticed patterns such as postprandial spikes or nocturnal highs.

CGM also delivers a detailed and comprehensive glucose profile for healthcare providers, including metrics such as time in range, hypoglycemia/hyperglycemia frequency, and glycemic variability. This enables more precise treatment intensification, risk stratification, and preventive strategies to lower hospitalization rates and avoid severe complications. The capability to remotely monitor patient data, enhanced by integrated wireless data transmission and cloud-based storage, streamlines care delivery and boosts adherence. This is particularly beneficial for vulnerable groups, including children, the elderly, pregnant women, and individuals with impaired awareness of hypoglycemia.

CGMs eliminate the practical and psychological burden of frequent finger sticks, a limitation that impaired adherence and quality of life with earlier methods. Children particularly value this "finger-prick-free" approach, and patients undergoing intensive therapy report higher treatment satisfaction and long-term device retention rates despite cost and device complexity challenges.

CGM encompasses dramatic improvements in glycemic control statistics, hypoglycemia prevention, patient empowerment through real-time data, holistic healthcare-team support with actionable metrics, and enhanced overall quality of life. With these clinically validated benefits, international diabetes care standards strongly recommend CGM for type 1 diabetes and expanding indications for type 2 diabetes. This reinforces CGM's role as a cornerstone of modern diabetes care.

The comparative company analysis evaluates and categorizes the continuous glucose monitoring device (CGMD) market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global continuous glucose monitoring device (CGMD) market. The key market players are Abbott Laboratories; Dexcom Inc., Ypsomed Holding AG, Medtronic, F. Hoffmann-La Roche Ltd, Senseonics Holdings Inc, i-SENS Inc., A. Menarini Diagnostics s.r.l, Tandem Diabetes Care, Inc., and Medtrum Technologies Inc.

Based on product, the continuous glucose monitoring device (CGMD) market is segmented into sensors, transmitters, and receivers. The sensors segment held the largest share of the market in 2024.

By application, the market is categorized into type 1 diabetes and type 2 diabetes. The type 2 diabetes segment accounted for the largest continuous glucose monitoring device (CGMD) market share in 2024.

By testing sites, the market is categorized into fingertip testing and alternate site testing. The fingertip testing segment accounted for the largest share of the continuous glucose monitoring device (CGMD) market in 2024. Fingertip blood glucose testing, also known as self-monitoring of blood glucose (SMBG), has long been the foundation of diabetes management. It offers direct capillary blood readings by pricking a finger and applying a drop to a meter. Though CGMs increasingly dominate due to their continuous and trend-focused data, finger sticks remain essential for calibration (in some CGMs) and confirmation during rapid glucose changes or suspected measurement errors.

Accuracy remains one of SMBG's advantages. Modern fingerstick meters typically demonstrate lower Mean Absolute Relative Difference (MARD), often in the 5-6% range, compared to around 8-9% for top-tier CGMs such as the Dexcom G7 and FreeStyle Libre 3. This edge in accuracy is particularly valuable in situations requiring precise glucose readings, such as confirming hypoglycemia or calibrating CGMs. Lag time and interstitial vs. capillary fluid differences remain key distinctions. CGMs measure interstitial fluid glucose, which typically lags behind blood glucose by ~5-15 minutes. Behind actual blood glucose, Fingerstick testing provides immediate access to true capillary glucose levels, making it invaluable when rapid changes occur or device alerts seem inconsistent with symptoms.

Regarding end user, the continuous glucose monitoring device (CGMD) market is segmented into hospitals and clinics, and self or homecare. The self or homecare segment held the largest share of the continuous glucose monitoring device (CGMD) market in 2024.

Companies operating in the continuous glucose monitoring device (CGMD) market adopt various organic and inorganic strategies. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaborations, and partnerships. These growth strategies allow the market players to expand their businesses, enhance their geographic presence, and contribute to the overall market growth. Furthermore, acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few significant developments by key continuous glucose monitoring device (CGMD) market players are listed below.

In July 2025, Abbott obtained FDA approvals for two new over-the-counter (OTC) continuous glucose monitoring systems, Lingo and Libre Rio. These are based on the FreeStyle Libre technology, expanding access to glucose monitoring beyond traditional diabetes management to general health and wellness. This is a major step in consumerizing IoT medical devices.

In July 2025, DexCom, Inc. announced it has released a new AI-powered photo meal logging feature to Stelo, the first over-the-counter glucose biosensor cleared1 by the FDA in the US. Dexcom's Smart Food Logging feature encourages and enables users to log their meals more consistently. Stelo and Dexcom G7 users can now take a photo of their food in the app, where AI will automatically identify the ingredients and populate the meal description. Dexcom G7 is the US's only prescription continuous glucose monitors to support photo logging.

In April 2025, DexCom, Inc. announced the FDA has cleared the Dexcom G7 15-Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes in the United States. With an overall MARD of 8.0%,3 Dexcom G7 15 Day builds on the performance of Dexcom CGM, which is clinically proven to lower A1C, reduce hyper- and hypoglycemia, and increase time in range.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Analyst Market Outlook
  • 2.2 Market Attractiveness

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:
  • 3.3 Assumptions and Limitations

4. Continuous Glucose Monitoring Device (CGMD) Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Continuous Glucose Monitoring Device (CGMD) Market - Key Market Dynamics

  • 5.1 Continuous Glucose Monitoring Device (CGMD) Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Rising Global Prevalence of Diabetes
    • 5.2.2 Growing Technological Advancements in CGM Devices
    • 5.2.3 Benefits Over Conventional Glucose Monitoring
  • 5.3 Market Restraints
    • 5.3.1 High Cost and Limited Reimbursement
    • 5.3.2 User Comfort and Wearability Challenges
  • 5.4 Market Opportunities
    • 5.4.1 Increasing Accessibility in Emerging and Underserved Markets
  • 5.5 Future Trends
    • 5.5.1 Integration with Insulin Delivery and AI-Driven Decision Support
  • 5.6 Impact of Drivers and Restraints:

6. Continuous Glucose Monitoring Device (CGMD) Market - Global Market Analysis

  • 6.1 Continuous Glucose Monitoring Device (CGMD) Market Revenue (US$ Million), 2021-2031
  • 6.2 Continuous Glucose Monitoring Device (CGMD) Market Forecast Analysis

7. Continuous Glucose Monitoring Device (CGMD) Market Analysis - by Product

  • 7.1 Sensors
    • 7.1.1 Overview
    • 7.1.2 Sensors: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Transmitters
    • 7.2.1 Overview
    • 7.2.2 Transmitters: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Receivers
    • 7.3.1 Overview
    • 7.3.2 Receivers: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)

8. Continuous Glucose Monitoring Device (CGMD) Market Analysis - by Application

  • 8.1 Type 1 Diabetes
    • 8.1.1 Overview
    • 8.1.2 Type 1 Diabetes: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Type 2 Diabetes
    • 8.2.1 Overview
    • 8.2.2 Type 2 Diabetes: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)

9. Continuous Glucose Monitoring Device (CGMD) Market Analysis - by Testing Sites

  • 9.1 Fingertip Testing
    • 9.1.1 Overview
    • 9.1.2 Fingertip Testing: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Alternate Site Testing
    • 9.2.1 Overview
    • 9.2.2 Alternate Site Testing: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)

10. Continuous Glucose Monitoring Device (CGMD) Market Analysis - by End User

  • 10.1 Hospitals and Clinics
    • 10.1.1 Overview
    • 10.1.2 Hospitals and Clinics: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Self or Homecare
    • 10.2.1 Overview
    • 10.2.2 Self or Homecare: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)

11. Continuous Glucose Monitoring Device (CGMD) Market - Geographical Analysis

  • 11.1 Overview
  • 11.2 North America
    • 11.2.1 North America Continuous Glucose Monitoring Device (CGMD) Market Overview
    • 11.2.2 North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2031 (US$ Million)
    • 11.2.3 North America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
      • 11.2.3.1 North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Product
    • 11.2.4 North America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
      • 11.2.4.1 North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Application
    • 11.2.5 North America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
      • 11.2.5.1 North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Testing Sites
    • 11.2.6 North America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.2.6.1 North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by End User
    • 11.2.7 North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Country
      • 11.2.7.1 North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Country
      • 11.2.7.2 United States: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.7.2.1 United States: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.2.7.2.2 United States: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.2.7.2.3 United States: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.2.7.2.4 United States: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.2.7.3 Canada: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.7.3.1 Canada: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.2.7.3.2 Canada: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.2.7.3.3 Canada: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.2.7.3.4 Canada: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.2.7.4 Mexico: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.7.4.1 Mexico: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.2.7.4.2 Mexico: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.2.7.4.3 Mexico: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.2.7.4.4 Mexico: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
  • 11.3 Europe
    • 11.3.1 Europe Continuous Glucose Monitoring Device (CGMD) Market Overview
    • 11.3.2 Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2031 (US$ Million)
    • 11.3.3 Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
      • 11.3.3.1 Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Product
    • 11.3.4 Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
      • 11.3.4.1 Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Application
    • 11.3.5 Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
      • 11.3.5.1 Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Testing Sites
    • 11.3.6 Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.3.6.1 Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by End User
    • 11.3.7 Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Country
      • 11.3.7.1 Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Country
      • 11.3.7.2 Germany: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.7.2.1 Germany: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.3.7.2.2 Germany: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.3.7.2.3 Germany: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.3.7.2.4 Germany: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.3.7.3 United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.7.3.1 United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.3.7.3.2 United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.3.7.3.3 United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.3.7.3.4 United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.3.7.4 France: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.7.4.1 France: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.3.7.4.2 France: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.3.7.4.3 France: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.3.7.4.4 France: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.3.7.5 Italy: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.7.5.1 Italy: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.3.7.5.2 Italy: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.3.7.5.3 Italy: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.3.7.5.4 Italy: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.3.7.6 Spain: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.7.6.1 Spain: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.3.7.6.2 Spain: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.3.7.6.3 Spain: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.3.7.6.4 Spain: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.3.7.7 Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.7.7.1 Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.3.7.7.2 Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.3.7.7.3 Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.3.7.7.4 Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
  • 11.4 Asia Pacific
    • 11.4.1 Asia Pacific Continuous Glucose Monitoring Device (CGMD) Market Overview
    • 11.4.2 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2031 (US$ Million)
    • 11.4.3 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
      • 11.4.3.1 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Product
    • 11.4.4 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
      • 11.4.4.1 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Application
    • 11.4.5 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
      • 11.4.5.1 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Testing Sites
    • 11.4.6 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.4.6.1 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by End User
    • 11.4.7 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Country
      • 11.4.7.1 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Country
      • 11.4.7.2 China: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.7.2.1 China: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.4.7.2.2 China: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.4.7.2.3 China: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.4.7.2.4 China: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.4.7.3 India: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.7.3.1 India: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.4.7.3.2 India: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.4.7.3.3 India: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.4.7.3.4 India: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.4.7.4 Japan: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.7.4.1 Japan: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.4.7.4.2 Japan: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.4.7.4.3 Japan: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.4.7.4.4 Japan: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.4.7.5 South Korea: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.7.5.1 South Korea: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.4.7.5.2 South Korea: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.4.7.5.3 South Korea: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.4.7.5.4 South Korea: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.4.7.6 Australia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.7.6.1 Australia: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.4.7.6.2 Australia: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.4.7.6.3 Australia: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.4.7.6.4 Australia: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.4.7.7 Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.7.7.1 Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.4.7.7.2 Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.4.7.7.3 Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.4.7.7.4 Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
  • 11.5 Middle East and Africa
    • 11.5.1 Middle East and Africa Continuous Glucose Monitoring Device (CGMD) Market Overview
    • 11.5.2 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2031 (US$ Million)
    • 11.5.3 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
      • 11.5.3.1 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Product
    • 11.5.4 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
      • 11.5.4.1 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Application
    • 11.5.5 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
      • 11.5.5.1 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Testing Sites
    • 11.5.6 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.5.6.1 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by End User
    • 11.5.7 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Country
      • 11.5.7.1 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Country
      • 11.5.7.2 Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.5.7.2.1 Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.5.7.2.2 Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.5.7.2.3 Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.5.7.2.4 Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.5.7.3 South Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.5.7.3.1 South Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.5.7.3.2 South Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.5.7.3.3 South Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.5.7.3.4 South Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.5.7.4 United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.5.7.4.1 United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.5.7.4.2 United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.5.7.4.3 United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.5.7.4.4 United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.5.7.5 Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.5.7.5.1 Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.5.7.5.2 Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.5.7.5.3 Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.5.7.5.4 Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
  • 11.6 South and Central America
    • 11.6.1 South and Central America Continuous Glucose Monitoring Device (CGMD) Market Overview
    • 11.6.2 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2031 (US$ Million)
    • 11.6.3 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
      • 11.6.3.1 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Product
    • 11.6.4 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
      • 11.6.4.1 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Application
    • 11.6.5 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
      • 11.6.5.1 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Testing Sites
    • 11.6.6 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.6.6.1 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by End User
    • 11.6.7 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Country
      • 11.6.7.1 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Country
      • 11.6.7.2 Brazil: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.6.7.2.1 Brazil: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.6.7.2.2 Brazil: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.6.7.2.3 Brazil: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.6.7.2.4 Brazil: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.6.7.3 Argentina: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.6.7.3.1 Argentina: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.6.7.3.2 Argentina: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.6.7.3.3 Argentina: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.6.7.3.4 Argentina: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.6.7.4 Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.6.7.4.1 Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.6.7.4.2 Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.6.7.4.3 Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.6.7.4.4 Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User

12. Competitive Landscape

  • 12.1 Heat Map Analysis by Key Players
  • 12.2 Company Positioning & Concentration

13. Global Continuous Glucose Monitoring Device Market Industry Landscape

  • 13.1 Overview
  • 13.2 Product Launch, Product Approvals
  • 13.3 Expansions And Other Strategic Developments

14. Company Profiles

  • 14.1 Abbott Laboratories
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Dexcom Inc
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Ypsomed Holding AG
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Medtronic Plc
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 F. Hoffmann-La Roche Ltd
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Senseonics Holdings Inc
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 i-SENS Inc
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 A. Menarini Diagnostics s.r.l
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Tandem Diabetes Care Inc
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Medtrum Technologies Inc.
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 List of Abbreviations

List Of Tables

  • Table 1. Continuous Glucose Monitoring Device (CGMD) Market Segmentation
  • Table 2. Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million)
  • Table 3. Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million)
  • Table 4. Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 5. Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 6. Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 7. Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 8. Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 9. Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 10. Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 11. Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 12. North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 13. North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 14. North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 15. North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 16. North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 17. North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 18. North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 19. North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 20. North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 21. North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 22. United States: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 23. United States: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 24. United States: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 25. United States: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 26. United States: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 27. United States: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 28. United States: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 29. United States: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 30. Canada: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 31. Canada: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 32. Canada: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 33. Canada: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 34. Canada: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 35. Canada: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 36. Canada: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 37. Canada: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 38. Mexico: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 39. Mexico: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 40. Mexico: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 41. Mexico: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 42. Mexico: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 43. Mexico: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 44. Mexico: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 45. Mexico: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 46. Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 47. Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 48. Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 49. Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 50. Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 51. Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 52. Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 53. Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 54. Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 55. Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 56. Germany: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 57. Germany: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 58. Germany: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 59. Germany: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 60. Germany: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 61. Germany: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 62. Germany: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 63. Germany: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 64. United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 65. United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 66. United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 67. United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 68. United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 69. United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 70. United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 71. United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 72. France: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 73. France: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 74. France: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 75. France: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 76. France: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 77. France: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 78. France: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 79. France: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 80. Italy: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 81. Italy: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 82. Italy: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 83. Italy: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 84. Italy: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 85. Italy: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 86. Italy: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 87. Italy: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 88. Spain: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 89. Spain: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 90. Spain: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 91. Spain: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 92. Spain: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 93. Spain: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 94. Spain: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 95. Spain: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 96. Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 97. Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 98. Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 99. Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 100. Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 101. Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 102. Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 103. Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 104. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 105. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 106. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 107. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 108. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 109. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 110. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 111. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 112. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 113. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 114. China: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 115. China: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 116. China: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 117. China: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 118. China: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 119. China: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 120. China: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 121. China: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 122. India: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 123. India: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 124. India: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 125. India: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 126. India: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 127. India: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 128. India: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 129. India: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 130. Japan: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 131. Japan: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 132. Japan: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 133. Japan: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 134. Japan: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 135. Japan: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 136. Japan: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 137. Japan: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 138. South Korea: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 139. South Korea: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 140. South Korea: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 141. South Korea: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 142. South Korea: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 143. South Korea: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 144. South Korea: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 145. South Korea: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 146. Australia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 147. Australia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 148. Australia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 149. Australia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 150. Australia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 151. Australia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 152. Australia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 153. Australia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 154. Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 155. Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 156. Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 157. Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 158. Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 159. Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 160. Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 161. Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 162. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 163. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 164. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 165. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 166. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 167. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 168. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 169. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 170. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 171. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 172. Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 173. Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 174. Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 175. Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 176. Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 177. Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 178. Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 179. Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 180. South Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 181. South Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 182. South Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 183. South Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 184. South Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 185. South Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 186. South Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 187. South Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 188. United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 189. United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 190. United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 191. United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 192. United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 193. United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 194. United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 195. United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 196. Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 197. Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 198. Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 199. Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 200. Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 201. Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 202. Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 203. Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 204. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 205. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 206. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 207. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 208. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 209. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 210. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 211. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 212. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 213. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 214. Brazil: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 215. Brazil: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 216. Brazil: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 217. Brazil: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 218. Brazil: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 219. Brazil: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 220. Brazil: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 221. Brazil: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 222. Argentina: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 223. Argentina: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 224. Argentina: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 225. Argentina: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 226. Argentina: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 227. Argentina: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 228. Argentina: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 229. Argentina: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 230. Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 231. Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 232. Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 233. Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 234. Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 235. Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 236. Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 237. Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 238. Heat Map Analysis by Key Players
  • Table 239. List of Abbreviations

List Of Figures

  • Figure 1. Continuous Glucose Monitoring Device (CGMD) Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Continuous Glucose Monitoring Device (CGMD) Market Revenue (US$ Million), 2021-2031
  • Figure 5. Continuous Glucose Monitoring Device (CGMD) Market Share (%) - by Product (2024 and 2031)
  • Figure 6. Sensors: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Transmitters: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Receivers: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Continuous Glucose Monitoring Device (CGMD) Market Share (%) - by Application (2024 and 2031)
  • Figure 10. Type 1 Diabetes: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Type 2 Diabetes: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Continuous Glucose Monitoring Device (CGMD) Market Share (%) - by Testing Sites (2024 and 2031)
  • Figure 13. Fingertip Testing: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Alternate Site Testing: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Continuous Glucose Monitoring Device (CGMD) Market Share (%) - by End User (2024 and 2031)
  • Figure 16. Hospitals and Clinics: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Self or Homecare: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Continuous Glucose Monitoring Device (CGMD) Market Breakdown by Region, 2024 and 2031 (%)
  • Figure 19. North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2031 (US$ Million)
  • Figure 20. North America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product (2024 and 2031)
  • Figure 21. North America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application (2024 and 2031)
  • Figure 22. North America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites (2024 and 2031)
  • Figure 23. North America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User (2024 and 2031)
  • Figure 24. North America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 25. United States: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 26. Canada: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 27. Mexico: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 28. Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2031 (US$ Million)
  • Figure 29. Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product (2024 and 2031)
  • Figure 30. Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application (2024 and 2031)
  • Figure 31. Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites (2024 and 2031)
  • Figure 32. Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User (2024 and 2031)
  • Figure 33. Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 34. Germany: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 35. United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 36. France: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 37. Italy: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 38. Spain: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 39. Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 40. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2031 (US$ Million)
  • Figure 41. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product (2024 and 2031)
  • Figure 42. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application (2024 and 2031)
  • Figure 43. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites (2024 and 2031)
  • Figure 44. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User (2024 and 2031)
  • Figure 45. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 46. China: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 47. India: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 48. Japan: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 49. South Korea: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 50. Australia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 51. Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 52. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2031 (US$ Million)
  • Figure 53. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product (2024 and 2031)
  • Figure 54. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application (2024 and 2031)
  • Figure 55. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites (2024 and 2031)
  • Figure 56. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User (2024 and 2031)
  • Figure 57. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 58. Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 59. South Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 60. United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 61. Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 62. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2031 (US$ Million)
  • Figure 63. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product (2024 and 2031)
  • Figure 64. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application (2024 and 2031)
  • Figure 65. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites (2024 and 2031)
  • Figure 66. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User (2024 and 2031)
  • Figure 67. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 68. Brazil: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 69. Argentina: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 70. Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 71. Company Positioning & Concentration